Fibrosis Bibliography of free accessible medical and biological reviews

Nr.	Year OPEN	Title	rate good	rate bad	no link	Citation
1	2003	Fibrosis regression induced by intravenous gammaglobulin treatment.	+	-	nl	Ann Rheum Dis 62(2):175-7 (2003)
2	2008	Mechanisms of fibrogenesis.	+	-	nl	Exp Biol Med (Maywood) 233(2):109-22 (2008)
3	2002	Transforming growth factor-beta signal transduction and progressive renal disease.	+	-	nl	Exp Biol Med (Maywood) 227(11):943-56 (2002)
4	2008	Molecular ablation of transforming growth factor beta signaling pathways by tyrosine kinase inhibition: the coming of a promising new era in the treatment of tissue fibrosis.	+	-	nl	Arthritis Rheum 58(8):2219-24 (2008) Rosenbloom J
5	2008	Hypoxia-inducible factor signaling in the development of tissue fibrosis.	+	-	nl	Cell Cycle 7(9):1128-32 (2008)
6	2002	Gene expression in fibroblasts and fibrosis: involvement in cardiac hypertrophy.	+	-	nl	Circ Res 91(12):1103-13 (2002)
7	2006	Peroxisome proliferator-activated receptor gamma agonists in renal disease.	+	-	nl	Eur J Endocrinol 154(5):613-21 (2006)
8	2007	Fibrosis and diseases of the eye.	+	-	nl	J Clin Invest 117(3):576-86 (2007)
9	2007	Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ.	+	-	nl	J Clin Invest 117(3):539-48 (2007)
10	2007	Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases.	+	-	nl	J Clin Invest 117(3):524-9 (2007)
11	2005	Liver fibrosis.	+	-	nl	J Clin Invest 115(2):209-18 (2005)
12	2004	Pulmonary fibrosis: thinking outside of the lung.	+	-	nl	J Clin Invest 114(3):319-21 (2004)
13	2009	Matrix metalloproteinases and their inhibitors as markers of inflammation and fibrosis in chronic liver disease (Review).	+	-	nl	Int J Mol Med 24(2):143-52 (2009)
14	2008	The controversial role of tumor necrosis factor alpha in fibrotic diseases.	+	-	nl	Arthritis Rheum 58(8):2228-35 (2008)
15	2009	Stimulatory autoantibodies to platelet-derived growth factor receptors in systemic sclerosis: what functional autoimmunity could learn from receptor biology.	+	-	nl	Arthritis Rheum 60(4):907-11 (2009)
16	2003	Wnt signaling and pulmonary fibrosis.	+	-	nl	Am J Pathol 162(5):1393-7 (2003)
17	2009	Emerging concepts in the pathogenesis of lung fibrosis.	+	-	nl	Am J Pathol 175(1):3-16 (2009)
18	2005	A murine model of alcoholic cardiomyopathy: a role for zinc and metallothionein in fibrosis.	+	-	nl	Am J Pathol 167(2):301-4 (2005)
19	2009	Integrin-mediated transforming growth factor-beta activation, a potential therapeutic target in fibrogenic disorders.	+	-	nl	Am J Pathol 175(4):1362-70 (2009)
20	2008	Endocannabinoids and liver disease. II. Endocannabinoids in the pathogenesis and treatment of liver fibrosis.	+	-	nl	Am J Physiol Gastrointest Liver Physiol 294(2):G357-62 (2008)
21	2010	Role of lysyl oxidase in myocardial fibrosis: from basic science to clinical aspects.	+	-	nl	Am J Physiol Heart Circ Physiol 299(1):H1-9 (2010)
22	2009	Could N-acetylcysteine slow progression of idiopathic pulmonary fibrosis by inhibiting EMT?	+	-	nl	Am J Physiol Lung Cell Mol Physiol 297(5):L803-4 (2009) Wolters PJ
23	2008	Caveolin-1 stops profibrogenic signaling?	+	-	nl	Am J Physiol Lung Cell Mol Physiol 294(5):L841-2 (2008)
24	2008	Antifibrotic properties of caveolin-1 scaffolding domain in vitro and in vivo.	+	-	nl	Am J Physiol Lung Cell Mol Physiol 294(5):L843-61 (2008)
25	2008	Lysophosphatidic acid and renal fibrosis.	+	-	nl	Biochim Biophys Acta 1781(9):582-7 (2008)
26	2010	Signaling pathways in the epithelial origins of pulmonary fibrosis.	+	-	nl	Cell Cycle 9(14):2769-76 (2010)
27	2007	Reactivation of Snail genes in renal fibrosis and carcinomas: a process of reversed embryogenesis?	+	-	nl	Cell Cycle 6(6):638-42 (2007)
28	2011	Targeting collagen expression in alcoholic liver disease.	+	-	nl	World J Gastroenterol 17(20):2473-81 (2011)
29	2007	Transforming growth factor-beta and fibrosis.	+	-	nl	World J Gastroenterol 13(22):3056-62 (2007) Verrecchia F
30	2007	Role of iron in hepatic fibrosis: one piece in the puzzle.	+	-	nl	World J Gastroenterol 13(35):4746-54 (2007)
31	2009	Renin-angiotensin system in the pathogenesis of liver fibrosis.	+	-	nl	World J Gastroenterol 15(21):2579-86 (2009)
32	2010	Syndecan-1: a critical mediator in cardiac fibrosis.	+	-	nl	Hypertension 55(2):233-5 (2010)
33	2006	Are peroxisome proliferator-activated receptors new therapeutic targets in diabetic and non-diabetic nephropathies?	+	-	nl	Nephrol Dial Transplant 21(10):2696-702 (2006)
34	2006	Renal fibrosis and the origin of the renal fibroblast.	+	-	nl	Nephrol Dial Transplant 21(12):3368-70 (2006)
35	2003	The thrombospondin 1-TGF-beta axis in fibrotic renal disease.	+	-	nl	Nephrol Dial Transplant 18(7):1241-5 (2003)
36	2007	Molecular targets in pulmonary fibrosis: the myofibroblast in focus.	+	-	nl	Chest 132(4):1311-21 (2007)
37	2010	Potential therapeutic targets for cardiac fibrosis: TGFbeta, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation.	+	-	nl	Circ Res 106(11):1675-80 (2010)
38	2010	Protein acetylation in the cardiorenal axis: the promise of histone deacetylase inhibitors.	+	-	nl	Circ Res 106(2):272-84 (2010)
39	2009	"Obese" smooth muscle cells fail to assemble collagen fibrils.	+	-	nl	Circ Res 104(7):826-8 (2009) Leitinger N
40	2011	A transgenic mouse model for studying the role of the parathyroid hormone-related protein system in renal injury.	+	-	nl	J Biomed Biotechnol 2011(-):290874 (2011)
41	2007	TGFbeta, cardiac fibroblasts, and the fibrotic response.	+	-	nl	Cardiovasc Res 74(2):207-12 (2007)
42	2007	TGF-beta signaling in vascular fibrosis.	+	-	nl	Cardiovasc Res 74(2):196-206 (2007)
43	2008	Fibrogenesis of parenchymal organs.	+	-	nl	Proc Am Thorac Soc 5(3):338-42 (2008)
44	2008	What differentiates normal lung repair and fibrosis? Inflammation, resolution of repair, and fibrosis.	+	-	nl	Proc Am Thorac Soc 5(3):305-10 (2008)
45	2006	Epithelial origin of myofibroblasts during fibrosis in the lung.	+	-	nl	Proc Am Thorac Soc 3(4):377-82 (2006)
46	2006	Transgenic modeling of transforming growth factor-beta(1): role of apoptosis in fibrosis and alveolar remodeling.	+	-	nl	Proc Am Thorac Soc 3(5):418-23 (2006)
47	2006	Transforming growth factor beta: a central modulator of pulmonary and airway inflammation and fibrosis.	+	-	nl	Proc Am Thorac Soc 3(5):413-7 (2006)
48	2007	Reversal of renal disease: is it enough to inhibit the action of angiotensin II?	+	-	nl	Cell Death Differ 14(7):1343-9 (2007)
49	2007	Therapeutic potential of follistatin to promote tissue regeneration and prevent tissue fibrosis.	+	-	nl	Endocr J 54(6):849-54 (2007)
50	2010	New approaches to blockade of the renin-angiotensin-aldosterone system: chymase as an important target to prevent organ damage.	+	-	nl	J Pharmacol Sci 113(4):301-9 (2010)
51	2009	Drug discovery for overcoming chronic kidney disease (CKD): new therapy for CKD by a (pro)renin-receptor-blocking decoy peptide.	+	-	nl	J Pharmacol Sci 109(1):20-3 (2009)
52	2010	Fibrocytes: bringing new insights into mechanisms of inflammation and fibrosis.	+	-	nl	Int J Biochem Cell Biol 42(4):535-42 (2010)
53	2009	Imatinib as a novel therapeutic approach for fibrotic disorders.	+	-	nl	Rheumatology (Oxford) 48(1):2-4 (2009) Distler JH
54	2008	Role of PDGF in fibrotic diseases and systemic sclerosis.	+	-	nl	Rheumatology (Oxford) 47 Suppl 5(-):v2-4 (2008)
55	2008	Criteria to select molecular targets for anti-fibrotic therapy.	+	-	nl	Rheumatology (Oxford) 47 Suppl 5(-):v12-3 (2008)
56	2008	Intracellular tyrosine kinases as novel targets for anti-fibrotic therapy in systemic sclerosis.	+	-	nl	Rheumatology (Oxford) 47 Suppl 5(-):v10-1 (2008)
57	2008	Extracellular superoxide dismutase in pulmonary fibrosis.	+	-	nl	Antioxid Redox Signal 10(2):343-54 (2008)
58	2008	Antioxidants as potential therapeutics for lung fibrosis.	+	-	nl	Antioxid Redox Signal 10(2):355-70 (2008)
59	2008	The role of inflammation in the pathogenesis of idiopathic pulmonary fibrosis.	+	-	nl	Antioxid Redox Signal 10(2):287-301 (2008)
60	2011	Resolving the scar of pulmonary fibrosis.	+	-	nl	N Engl J Med 365(12):1140-1 (2011) Downey GP
61	2004	Regression of liver fibrosis in patients treated by interferon.	+	-	nl	Intern Med 43(10):887-8 (2004)
62	2009	Rationale and targets for antifibrotic therapies.	+	-	nl	Gastroenterol Clin Biol 33(10-11):949-57 (2009)
63	2005	IL-6 and extracellular matrix remodeling.	+	-	nl	Rev Esp Enferm Dig 97(8):575-95 (2005)
64	2004	Hepatocyte growth factor in kidney fibrosis: therapeutic potential and mechanisms of action.	+	-	nl	Am J Physiol Renal Physiol 287(1):F7-16 (2004)
65	2003	TGF-beta signal transduction and mesangial cell fibrogenesis.	+	-	nl	Am J Physiol Renal Physiol 284(2):F243-52 (2003)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.